Association of diabetes and perineural invasion in pancreatic cancer
- PMID: 23342285
- PMCID: PMC3544459
- DOI: 10.1002/cam4.43
Association of diabetes and perineural invasion in pancreatic cancer
Abstract
Diabetes and perineural invasion are frequently observed in pancreatic cancer. In this study, we tested possible relations between diabetes and perineural invasion in patients with resected pancreatic cancer. We conducted a retrospective study in 544 cases of resected pancreatic adenocarcinoma seen at the University of Texas MD Anderson Cancer Center during 1996-2011. Information on tumor characteristics, diabetes history, and survival time was collected by personal interview and medical record review. Patients with diabetes before or at the time of the pancreatic cancer diagnosis were considered diabetes only. Pearson χ(2) test was used to compare categorical variables in diabetic and nondiabetic groups. Kaplan-Meier plot, log-rank test, and Cox proportional regression models were applied in survival analysis. The prevalence of diabetes and perineural invasion was 26.5% and 86.9%, respectively, in this study population. Patients with diabetes had a significantly higher prevalence of perineural invasion (92.4%) than those without diabetes (85%) (P = 0.025, χ(2) test). Diabetes was not associated with other pathological characteristics of the tumor, such as tumor size, lymphovascular invasion, tumor grade, lymph node metastasis, and resection margin status. Diabetic patients had a significantly lower frequency of abdominal pain (P = 0.01), but a slightly higher frequency of weight loss (P = 0.078) as early symptoms of their cancer. Both diabetes and perineural invasion were related to worse survival and increased risk of death after adjusting for tumor grade and margin and node status (P = 0.036 and 0.019, respectively). The observed associations of diabetes and perineural invasion as well as reduced frequency of pain as early symptom of pancreatic cancer support the hypothesis that diabetes may contribute to pancreatic progression via the mechanism of nerve damage.
Keywords: Diabetes; neuropathy; pancreatic cancer; perineural invasion.
Figures
Similar articles
-
The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection.Surg Today. 1999;29(1):16-22. doi: 10.1007/BF02482964. Surg Today. 1999. PMID: 9934826
-
Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma.PLoS One. 2016 Oct 12;11(10):e0164195. doi: 10.1371/journal.pone.0164195. eCollection 2016. PLoS One. 2016. PMID: 27732623 Free PMC article.
-
Prospective Evaluation of Associations between Cancer-Related Pain and Perineural Invasion in Patients with Resectable Pancreatic Adenocarcinoma.J Gastrointest Surg. 2017 Oct;21(10):1658-1665. doi: 10.1007/s11605-017-3513-z. Epub 2017 Aug 7. J Gastrointest Surg. 2017. PMID: 28785934 Clinical Trial.
-
Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.World J Gastroenterol. 2017 Sep 21;23(35):6420-6428. doi: 10.3748/wjg.v23.i35.6420. World J Gastroenterol. 2017. PMID: 29085191 Free PMC article. Review.
-
Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.HPB (Oxford). 2016 Jan;18(1):21-8. doi: 10.1016/j.hpb.2015.07.009. Epub 2015 Dec 21. HPB (Oxford). 2016. PMID: 26776847 Free PMC article. Review.
Cited by
-
Diabetes Mellitus and Pancreatic Ductal Adenocarcinoma-Prevalence, Clinicopathological Variables, and Clinical Outcomes.Cancers (Basel). 2022 Jun 8;14(12):2840. doi: 10.3390/cancers14122840. Cancers (Basel). 2022. PMID: 35740504 Free PMC article.
-
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.World J Gastroenterol. 2016 Jul 28;22(28):6424-33. doi: 10.3748/wjg.v22.i28.6424. World J Gastroenterol. 2016. PMID: 27605878 Free PMC article. Review.
-
The tumor microenvironment of pancreatic adenocarcinoma and immune checkpoint inhibitor resistance: a perplex relationship.Cancer Drug Resist. 2020 Sep 4;3(4):699-709. doi: 10.20517/cdr.2020.48. eCollection 2020. Cancer Drug Resist. 2020. PMID: 35582227 Free PMC article. Review.
-
Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis.Onco Targets Ther. 2016 Mar 22;9:1679-88. doi: 10.2147/OTT.S95744. eCollection 2016. Onco Targets Ther. 2016. PMID: 27042122 Free PMC article.
-
Pain sensation in pancreatic diseases is not uniform: the different facets of pancreatic pain.World J Gastroenterol. 2014 Jul 21;20(27):9154-61. doi: 10.3748/wjg.v20.i27.9154. World J Gastroenterol. 2014. PMID: 25083089 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012;62:10–29. - PubMed
-
- Pour PM, Bell RH, Batra SK. Neural invasion in the staging of pancreatic cancer. Pancreas. 2003;26:322–325. - PubMed
-
- Bapat AA, Hostetter G, Han DD, Von Hoff H. Perineural invasion and associated pain in pancreatic cancer. Nat. Rev. Cancer. 2011;11:695–707. - PubMed
-
- Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115:3379–3391. - PubMed
-
- Ceyhan GO, Michalski CW, Demir IE, Muller MW, Friess H. Pancreatic pain. Best Pract. Res. Clin. Gastroenterol. 2008;22:31–44. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical